title: Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
authors.affiliation: Department of Dermatology, Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France. gilles.safa@ch-stbrieuc.fr
authors.forename: Gilles
authors.initials: G
authors.lastname: Safa
authors.forename: Antoine
authors.initials: A
authors.lastname: Martin
authors.forename: Laure
authors.initials: L
authors.lastname: Darrieux
mesh_terms: D000208:Acute Disease; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000008:administration & dosage; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy*; D017211:Treatment Failure; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000069285:Infliximab; D000069549:Ustekinumab; D008727:Methotrexate